Part-Time

Medical Laboratory Scientist Point of Care Testing Specialist

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$34.13 - $49.63/hr

Boston, MA, USA

In Person

Onsite at 243-245 Charles Street, Boston, MA.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Data Analysis

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • Bachelor's Degree Medical Laboratory Science required or Bachelor's Degree Related Field of Study required
  • Can this role accept experience in lieu of a degree No
  • Medical Technologist (ASCP) - American Society for Clinical Pathology Board of Certification (ASCP-BOC) required
  • Clinical Laboratory experience as required to serve as the CLIA Technical Consultant 5-7 years required
  • The advanced knowledge, both practical and theoretical, of tests and procedures necessary to review findings and advise testing personnel.
  • Demonstrates an advanced level of analytical skills and judgment.
  • Must be able to effectively evaluate the accuracy of results.
  • Able to pay consistent attention to detail.
  • The manual/visual dexterity and skills necessary to operate, adjust, and make repairs to various types of automated and non-automated laboratory equipment.
  • Must have an advanced understanding of laboratory equipment and its operation, maintenance, and repair, and analytic techniques and IQCPs.
  • Can recognize problems with tests, QC, analyzers, and samples that could impact test results.
  • Demonstrates ability to contribute to the review or development of new procedures.
  • Demonstrates ability to identify and contribute to performance improvement, work re-design, or quality/safety projects.
  • Must have the ability to work independently, evaluate situations, and act appropriately. Ability to multitask in a fast-paced environment.
  • Must have basic computer skills, knowledge of Microsoft Office, and the ability to compile and analyze data.
  • Must have the ability to pay careful attention to detail and to adhere to written protocols.
  • Must be able to perform as a team member, provide leadership, guidance, and direction to staff.
  • The supervisory and managerial abilities necessary to direct and coordinate the activities of personnel/indirect staff and POCT operations.
  • Ability to oversee staff and make operational decisions.
  • Excellent communication and interpersonal skills. Ability to interact professionally and effectively with numerous staff, including physicians, hospital personnel, employees, vendors, and patients.
Responsibilities
  • Responsible for the recommendation of test methodology appropriate for the clinical use of the test results.
  • Responsible for the recommendation of test methodologies/instrumentation, including test performance characteristics, precision, and accuracy appropriate for the clinical use of test results. Works in collaboration with vendors.
  • Responsible for ensuring enrollment and participation in a CMS-approved proficiency testing (PT) program for the testing performed; that PT samples are tested in accordance with CLIA requirements; that PT results are returned within the time frames established by the PT program; that PT reports are reviewed by the appropriate staff, including the CLIA Lab Director and Medical Director; and that corrective action plans are followed when PT results are found to be unacceptable or unsatisfactory.
  • Responsible for establishing a quality control program appropriate for the testing performed, establishing the parameters for acceptable levels of analytical performance, and ensuring that these levels are maintained throughout the entire testing process, from the initial receipt of the specimen through sample analysis and reporting of test results.
  • Responsible for resolving technical problems and ensuring that remedial actions are taken whenever test systems deviate from the established performance specifications.
  • Responsible for ensuring that processes (e.g., QC lockouts, repeat criteria, etc.) are in place to ensure that patient test results are not reported until corrective actions have been taken and the test system is functioning properly.
  • Responsible for developing the training needs of testing personnel and assuring that training and education are appropriate for the type and complexity of testing performed.
  • Responsible for developing competency assessment modules for testing personnel. In collaboration with testing location leadership, ensures competency assessments are completed and documented at required intervals. Non-waived testing requires competency assessment at least semi-annually during the first year and annually thereafter, unless test methodology or instrumentation changes.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.